摘要
本文选择了头孢拉定、氨苄西林－舒巴坦钠、头孢曲松钠３种静脉用抗生素治疗下呼吸道感染的方案。临床有效率分别为８６．８４％、８０．００％、９５．２４％。运用药物经济学费用－效果分析方法，得出其费用－效果比分别为２４１３．３６元、３５９７．３１元、４３９３．８５元。头孢拉定的治疗方案是最有效、安全、经济。利用此类方法可为我国有限的医疗资源合理分配提供依据。
Three therapeutic schemes for acute lower respiratory infections with intravenous drips of cefradine, ampicillin -sul-bactam or ceftriaxone sodium were compared. The effective rate were 86. 84% , 80. 00% and 95. 24% , respectively. By the cost-ef-fectiveness analysis of pharmacoeconomics, the costs were 2 413. 36,3 597. 31 and 4 393. 85 yuan, respectively. The cefradine schemewas the most effective,safe and inexpensive one.
出处
《中国药房》
CAS
CSCD
1999年第1期20-21,共2页
China Pharmacy
关键词
抗生素
静脉滴注
治疗
药物经济学
下呼吸道感染
lower respiratory tract infection pharmacoeconomics cost - effectiveness analysis
